Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study
TQB2450联合安罗替尼作为根治性同步或序贯放化疗后局限期小细胞肺癌维持治疗的疗效和安全性：一项前瞻性Ib期研究
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13885-8
Liu, Xiaoli; Yin, Xiaoyan; Zhuang, Lulu; Wen, Junxu; Wei, Zhonghui; Cui, Wenxing; Yu, Minghao; Zhao, Kaikai; Liu, Lanping; Kong, Lingling; Jiang, Liyang; Jing, Xuquan; Zhu, Hui; Wang, Xunqiang; Dong, Xinjun; Yu, Jinming; Meng, Xiangjiao
